Last reviewed · How we verify

NCT05769296: AUSSIE-1

Australian UCSF Concussion in Athletes

Completed Last updated 17 March 2023
What this trial tests

trial testing Headpulse measurements in Concussion, Mild in 34 participants. Completed in 1 October 2021.

Timeline
1 June 2021
Primary endpoint
1 October 2021
1 October 2021

Quick facts

Lead sponsorUniversity of California, San Francisco
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date1 June 2021
Primary completion1 October 2021
Estimated completion1 October 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Concussion, Mild. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Analysis of cardiac induced brain forces using cranial accelerometry has been shown to diagnose concussion in high school athletes. This trial expands on this observation by recording headpulse signals in a recently concussed athletes playing Australian rules football.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Headpulse measurements

Trials testing the same drug.

Other recruiting trials for Concussion, Mild

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05769296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing